Neurophet (380550.KQ) Stock Price

Neurophet Price

CLOSED
7,370.00
​
Market closed

Over the last 3 years Neurophet grew revenue by 59.3% annually, reaching 2.62 B KRW. For Neurophet, the net margin of -856.2% is up versus -2,831.1% a few years ago.

Neurophet stock price

Access this data via the Eulerpool API

Neurophet business model & stock analysis

Neurophet Inc is a KR-based company operating in Health Care Technology industry. The company is headquartered in Seoul, Seoul and currently employs 135 full-time employees. The company went IPO on 2025-07-25. Neurophet Inc is a Korea-based company principally engaged in the research, development and sales of brain imaging analysis software. The firm is mainly engaged in the development and sale of positron emission tomography (PET) image quantitative analysis software ‘Neurophet SCALE PET’, neurodegenerative brain disease diagnosis support software ‘Neurophet AQUA’ and other products. In addition, the Company is engaged in the development and sale of therapeutic medical devices. The firm is also engaged in the provision of medical artificial intelligence (AI) solutions.

Frequently asked questions about Neurophet

Converted at the current exchange rate, the Neurophet share trades at 4.91 EUR (7,370.00 KRW).

The revenue cannot currently be calculated for Neurophet.

The profit cannot currently be calculated for Neurophet.

The P/E ratio cannot be calculated for Neurophet at the moment.

The P/S cannot be calculated for Neurophet currently.

The Eulerpool Quality Score for Neurophet is 2/10.

The ISIN of Neurophet is KR7380550004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Neurophet is 380550.KQ. The ticker symbol is used to trade Neurophet shares on the stock exchange.

Fair ValueTerminal
7,443.70 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
19.37 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Jul 25, 2025
ISIN
KR7380550004
Cusip
Y62754109
Market capitalization
84.58 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
4.35
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-115.10 %
Last updated Oct 8, 2026, 3:37 PM

Neurophet Peer Group